Assignee
Bayer Pharma AG
DE·256 granted patents·199 pending applications·752 citations·filing 2004–2025
Top patents by PatentIndex Score
455 records- 0196US9549932B22-(morpholin-4-yl)-1,7-naphthyridinesBayer Pharma AG·Filed 2016·Granted Jan 24, 2017·26 cites·30 claims
- 0295US11478554B2Antibody drug conjugates (ADCS) having enzymatically cleavable groupsBayer Pharma AG·Filed 2021·Granted Oct 25, 2022·5 cites·20 claims
- 0395US10308634B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugsBayer Pharma AG·Filed 2015·Granted Jun 4, 2019·17 cites·27 claims
- 0494US10973923B2Site specific homogeneous with KSP inhibitorsBayer Pharma AG·Filed 2016·Granted Apr 13, 2021·8 cites·37 claims
- 0594US10759758B2Polymorphic form of N-{6-(hydroxypropan-2-yl)-2-[2-(methylsulphonyl)ethyl]-2H-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamideBayer Pharma AG·Filed 2017·Granted Sep 1, 2020·17 cites·10 claims
- 0694US10300062B2Bicyclically substituted uracils and the use thereofBayer Pharma AG·Filed 2018·Granted May 28, 2019·11 cites·21 claims
- 0794US10022453B2Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP)Bayer Pharma AG·Filed 2014·Granted Jul 17, 2018·16 cites·39 claims
- 0894US9126998B2Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their useBayer Pharma AG·Filed 2013·Granted Sep 8, 2015·17 cites·15 claims
- 0993US12478696B2Gadolinium chelate compounds for use in magnetic resonance imagingBayer Pharma AG·Filed 2024·Granted Nov 25, 2025·1 cites·14 claims
- 1093US10729680B25-substituted 2-(morpholin-4-yl)-1,7-naphthyridinesBayer Pharma AG·Filed 2017·Granted Aug 4, 2020·10 cites·14 claims
- 1193US9949978B2Bicyclically substituted uracils and the use thereofBayer Pharma AG·Filed 2016·Granted Apr 24, 2018·12 cites·42 claims
- 1293US9949977B2Bicyclically substituted uracils and the use thereofBayer Pharma AG·Filed 2016·Granted Apr 24, 2018·12 cites·19 claims
- 1393US9481672B2Bicyclically substituted uracils and the use thereofBayer Pharma AG·Filed 2013·Granted Nov 1, 2016·18 cites·44 claims
- 1492US11643469B2Specific antibody-drug-conjugates (ADCs) with KSP inhibitors and anti-CD123-antibodiesBayer Pharma AG·Filed 2022·Granted May 9, 2023·1 cites·15 claims
- 1592US11123439B2Antibody drug conjugates (ADCS) and antibody prodrug conjugates (APDCS) with enzymatically cleavable groupsBayer Pharma AG·Filed 2016·Granted Sep 21, 2021·8 cites·51 claims
- 1692US10793545B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugsBayer Pharma AG·Filed 2019·Granted Oct 6, 2020·7 cites·27 claims
- 1792US10744205B2Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with anti-CD123-antibodiesBayer Pharma AG·Filed 2016·Granted Aug 18, 2020·9 cites·28 claims
- 1892US9988367B2Amide-substituted pyridinyltriazole derivatives and uses thereofBayer Pharma AG·Filed 2017·Granted Jun 5, 2018·5 cites·14 claims
- 1991US11660351B2Antibody drug conjugates (ADCs) having enzymatically cleavable groupsBayer Pharma AG·Filed 2017·Granted May 30, 2023·5 cites·50 claims
- 2091US11491245B2Gadolinium chelate compounds for use in magnetic resonance imagingBayer Pharma AG·Filed 2020·Granted Nov 8, 2022·2 cites·12 claims
- 2190US12006303B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said substituted indazoles, and use of said substituted indazoles to produce drugsBayer Pharma AG·Filed 2022·Granted Jun 11, 2024·1 cites·24 claims
- 2290US12006304B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said substituted indazoles, and use of said substituted indazoles to produce drugsBayer Pharma AG·Filed 2022·Granted Jun 11, 2024·1 cites·9 claims
- 2390US11001636B2Specific antibody-drug-conjugates (ADCs) with KSP inhibitors and anti-CD123-antibodiesBayer Pharma AG·Filed 2017·Granted May 11, 2021·5 cites·15 claims
- 2490US10399977B2Process for preparing (4S)- 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide and purification thereof for use as a pharmaceutical active ingredientBayer Pharma AG·Filed 2018·Granted Sep 3, 2019·7 cites·24 claims
- 2590US9951086B2Indazolecarboxamides, processes for their preparation, pharmaceutical preparations comprising them and their use for producing medicamentsBayer Pharma AG·Filed 2014·Granted Apr 24, 2018·21 cites·19 claims
- 2690US8778964B2Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their useBayer Pharma AG·Filed 2013·Granted Jul 15, 2014·15 cites·6 claims
- 2790US8349820B2Use of estradiol valerate or 17β-estradiol in combination with dienogest for oral therapy to maintain and/or increase feminine libidoBayer Pharma AG·Filed 2007·Granted Jan 8, 2013·51 cites·6 claims
- 2889US11071788B2Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with antiB7H3-antibodiesBayer Pharma AG·Filed 2016·Granted Jul 27, 2021·6 cites·32 claims
- 2989US10918639B2Combination containing SGC stimulators and mineralocorticoid receptor antagonistsBayer Pharma AG·Filed 2017·Granted Feb 16, 2021·3 cites·19 claims
- 3089US10485880B2Antibody-drug conjugates (ADCs) of KSP inhibitors with aglycosylated anti-TWEAKR antibodiesBayer Pharma AG·Filed 2015·Granted Nov 26, 2019·11 cites·29 claims
- 3189US9993484B22-(morpholin-4-yl)-1,7-naphthyridinesBayer Pharma AG·Filed 2015·Granted Jun 12, 2018·4 cites·9 claims
- 3289US9822102B2Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disordersBayer Pharma AG·Filed 2016·Granted Nov 21, 2017·7 cites·7 claims
- 3389US8981104B25-aminotetrahydroquinoline-2-carboxylic acids and their useBayer Pharma AG·Filed 2013·Granted Mar 17, 2015·13 cites·12 claims
- 3488US10844016B2Aromatic sulfonamide derivativesBayer Pharma AG·Filed 2017·Granted Nov 24, 2020·7 cites·15 claims
- 3588US10722601B2Gadolinium chelate compounds for use in magnetic resonance imagingBayer Pharma AG·Filed 2018·Granted Jul 28, 2020·2 cites·16 claims
- 3688US9957235B2Benzimidazol-2-amines as mIDH1 inhibitorsBayer Pharma AG·Filed 2015·Granted May 1, 2018·8 cites·34 claims
- 3788US9434690B2Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disordersBayer Pharma AG·Filed 2014·Granted Sep 6, 2016·10 cites·8 claims
- 3888US8796305B2Carboxy-substituted imidazo[1,2-a]pyridinecarboxamides and their useBayer Pharma AG·Filed 2013·Granted Aug 5, 2014·14 cites·6 claims
- 3987US11685714B2Prodrugs of cytotoxic active agents having enzymatically cleavable groupsBayer Pharma AG·Filed 2017·Granted Jun 27, 2023·3 cites·30 claims
- 4087US10183932B2Substituted oxopyridine derivatives and use thereof cardiovascular disordersBayer Pharma AG·Filed 2017·Granted Jan 22, 2019·5 cites·8 claims
- 4187US9771352B2Hydroxyalkyl-substituted phenyltriazole derivatives and uses thereofBayer Pharma AG·Filed 2015·Granted Sep 26, 2017·8 cites·15 claims
- 4287US8946215B2Hydroxy-substituted imidazo[1,2-a]pyridinecarboxamides and their useBayer Pharma AG·Filed 2013·Granted Feb 3, 2015·10 cites·8 claims
- 4386US10501437B2Crystalline forms of N-[2-(3-Hydroxy-3-methylbutyl)-6-(2-hydroxypropan-2-yl)-2H-indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamideBayer Pharma AG·Filed 2017·Granted Dec 10, 2019·6 cites·12 claims
- 4486US10179123B22-aryl- and 2-arylalkyl-benzimidazoles as mIDH1 inhibitorsBayer Pharma AG·Filed 2016·Granted Jan 15, 2019·4 cites·15 claims
- 4586US10077265B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2015·Granted Sep 18, 2018·4 cites·14 claims
- 4686US9951027B2Benzimidazol-2-amines as MIDH1 inhibitorsBayer Pharma AG·Filed 2015·Granted Apr 24, 2018·8 cites·22 claims
- 4786US9598417B2(Aza)pyridopyrazolopyrimidinones and indazolopyrimidinones and their useBayer Pharma AG·Filed 2014·Granted Mar 21, 2017·11 cites·10 claims
- 4885US12559473B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugsBayer Pharma AG·Filed 2024·Granted Feb 24, 2026·0 cites·15 claims
- 4985US11529356B22-(morpholin-4-yl)-1,7-naphthyridinesBayer Pharma AG·Filed 2020·Granted Dec 20, 2022·1 cites·20 claims
- 5085US10772893B22-(morpholin-4-yl)-1,7-naphthyridinesBayer Pharma AG·Filed 2018·Granted Sep 15, 2020·2 cites·12 claims
Showing the top 50 of 455 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →